Peptide of the Week: Tirzepatide, a Game Changer for Type 2 Diabetes and Obesity Management Burick Center for Health and Wellness Tirzepatide Side Effects Lightheadedness: Causes and Management Fella Health Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Bpc 157 Injectables at 3500 box Pharmaceutical Injections in Mumbai ID: 2858922714791 A new study provides the first evidence in humans that tirzepatide modulates brain electrophysiology, with changes in low frequency accumbens power linked to food preoccupation.